Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-03

Clinical Trial Update: VSV-02 Compassionate Use in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update indicates compassionate-use testing of VSV-02 for advanced solid tumors, including melanoma, with recruitment ongoing at The First Affiliat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VSV-02 (vesicular stomatitis virus-based oncolytic therapy)

Snippet

Sponsor: The First Affiliated Hospital of Xinxiang Medical College | Conditions: Advanced Solid Tumor, Melanoma | Phase 1 | Status: RECRUITING